NIH Group Makes Gene Therapy Recommendation.(adverse effects lead to death of patient)(Brief Article)

A draft report of an NIH working group recommends the Recombinant DNA Advisory Committee (RAC) monitor and make public all serious adverse events that occur in gene therapy clinical trials. The Working Group On NIH Oversight of Clinical Gene Transfer Research was charged with evaluating the regulation in the wake of the death of an 18-year-old gene therapy patient last September and subsequent revelations that gene therapy researchers weren't reporting adverse events to the NIH and the RAC. In a leaked …